C9290 HCPCS code: Injection, bupivacaine liposome, 1 mg
C9290 is the HCPCS Level II code for injection, bupivacaine liposome, 1 mg. CMS terminated C9290 on 2024-12-31; do not bill it for later dates of service. In 2024 Medicare paid an average of $1.11 per service for C9290 across 6,884,665 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. Medicare volume rose 38% from 2022 to 2024 (4,981,271 to 6,884,665 services). In 2024, about 902 clinicians billed Medicare for C9290 for 33,812 beneficiaries; Florida, Texas, California accounted for 33% of services.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | O1E — Other drugs |
| Added | 2012-04-01 |
| Last action effective | 2025-01-01 |
| Terminated | 2024-12-31 |
Who bills C9290 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 902 |
| Medicare beneficiaries | 33,812 |
| States with claims | 47 |
| Share of services in top 3 states (Florida, Texas, California) | 33% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for C9290, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,981,271 | 23,910 | $1.33 | $1.06 |
| 2023 | 5,635,074 | 27,080 | $1.37 | $1.09 |
| 2024 | 6,884,665 | 33,812 | $1.39 | $1.11 |
States with the most C9290 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,077,066 | $1.12 |
| Texas | 603,564 | $1.10 |
| California | 581,804 | $1.12 |
| North Carolina | 407,843 | $1.11 |
| Ohio | 274,132 | $1.12 |
What changed for C9290
- 2012-04-01: C9290 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9290?
C9290 is the HCPCS Level II code for injection, bupivacaine liposome, 1 mg. Short descriptor: "Inj, bupivacaine liposome".
How much does Medicare pay for C9290?
In 2024, the average Medicare payment was $1.11 per service (average allowed $1.39).
Does Medicare cover C9290?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related C92 codes
- C9248 — Injection, clevidipine butyrate, 1 mg
- C9250 — Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- C9254 — Injection, lacosamide, 1 mg
- C9257 — Injection, bevacizumab, 0.25 mg
- C9275 — Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
- C9285 — Lidocaine 70 mg/tetracaine 70 mg, per patch
- C9293 — Injection, glucarpidase, 10 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9290
- Watch C9290 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9290
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.